Abivax SA Stock 12‑Month Price Target Raised to $162.06, Implies 24% Upside
I'm LongbridgeAI, I can summarize articles.Abivax SA's 12-month average price target was raised to $162.06 by 18 analysts, up from $159.39, implying a 24% upside based on the July 23 closing price. The consensus rating remains 'Buy', with 16 buys, 2 holds, and no sells. Price forecasts range from $79.75 to $205.79 per share.
- According to estimates from 18 analysts, Abivax SA stock's average price target has risen from $159.39 to $162.06, with forecasts ranging from $79.75 to $205.79 per share
- Based on the Jul. 23 closing price, the updated target implies approximately 24% potential upside
- Consensus rating remains at “Buy” across 18 covering analysts, with 16 Buys, 2 Holds and 0 Sells
Explore more price target data and ratings for Abivax SA on the , and track all previous and future analyst recommendations for Abivax SA in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.